U.S. Entertainment Stock News

Recently, FedEx reported earnings that missed expectations and lowered its full-year guidance, triggering concern over operational pressures and softening demand, with additional pressure from job cuts linked to a major client shifting supply chain strategy. While implementing cost-saving measures and gaining pharmaceutical logistics certification, questions remain about whether these challenges are unique to FedEx or reflect broader sector issues. We'll explore how FedEx's weaker outlook...

Securities class action lawsuits were filed after Sable Offshore Corp. was accused of making false or misleading statements about restarting oil production off California between May 19, 2025 and June 3, 2025, and a court imposed emergency operational restrictions on the company. This legal action underscores the significant risks that can arise from disclosure practices and regulatory challenges in the energy sector. We'll explore how legal risks from alleged misstatements about production...

Biogen (BIIB) has been making headlines after securing FDA approval for a new subcutaneous version of Leqembi, its Alzheimer’s treatment developed with Eisai. Unlike its previous formulations, this new option can be administered at home, potentially making ongoing care easier for patients and caregivers. In addition, Biogen’s late-stage clinical results with zorevunersen, developed in partnership with Stoke Therapeutics, point toward a real possibility of the first disease-modifying therapy...

Chipotle Mexican Grill (CMG) may not have grabbed headlines with a single event this week, but the recent share price action is prompting plenty of investors to reassess their next move. Whether you already hold CMG or are just watching from the sidelines, the latest performance might have you wondering if something is brewing beneath the surface, or if a quieter spell just means opportunity is knocking. Over the past year, Chipotle’s stock has given up 24% of its value, despite healthy...

Earlier in 2025, CareTrust REIT completed a major expansion by acquiring Care REIT in the UK, fueling a US$1.1 billion wave of new investments focused on senior housing and skilled nursing properties. The acquisition not only broadened CareTrust’s geographic reach, but also set the stage for management’s projection of strong normalized funds from operations growth for 2025 amid increasing demand for senior care. We will now examine how CareTrust’s entry into the UK senior care market may...

Yum China Holdings announced a US$270 million share repurchase plan for 2025 as part of a broader US$1.5 billion capital return strategy, signaling confidence in its business outlook and commitment to shareholder returns. This move follows an interim report showing strong first-half 2025 financial performance and upward revisions to analyst earnings estimates, highlighting both financial strength and positive momentum. We'll explore how the new share repurchase initiative may influence Yum...

Pathward Financial (CASH) just received another non-compliance notice from Nasdaq after missing the deadline to file its latest quarterly report. If you follow the company, this may have caught your attention, especially since it marks the second straight quarter Pathward has lagged behind on its required filings. Alongside the late reports, Pathward is restating several past quarters to address issues with how it recorded certain loans and third-party relationships in its Consumer Solutions...

Nebius Group recently increased its revenue guidance, forecasting an annualized run rate of US$900 million to US$1.1 billion by the end of 2025, while planning to quadruple global data center capacity and raising US$1 billion in convertible notes to fund its expansion. A key insight is Nebius Group's aggressive infrastructure investment signals confidence in sustained AI-driven demand and requires significant financial and operational execution to deliver on these ambitious growth...

KKR (KKR) just made a bold move that is catching the eye of many investors: the company has brought on Adam Selipsky, former CEO of Amazon Web Services, as its leading technology advisor. This hire is more than a high-profile résumé addition; it is a clear signal that KKR aims to be at the forefront of investing in global AI infrastructure. Selipsky’s know-how in building and scaling digital infrastructure puts KKR in a strong position to take advantage of the surging need for compute, data...

East West Bancorp (EWBC) has caught investors’ attention following its latest investor update, where the bank showcased strong financial results for the second quarter of 2025. Growth was propelled by both commercial and residential mortgage loans, and the company emphasized a 2% rise in average loans and deposits from the prior quarter. This consistent execution on its core strategies, especially around diversification and deposit management, has kept East West Bancorp at the forefront of...

Expro Group Holdings (NYSE:XPRO) just made headlines by setting a new world record for the heaviest casing string ever deployed offshore. By leveraging its advanced Blackhawk Gen III Wireless Top Drive Cement Head with SKYHOOK technology in a challenging Gulf of America project for a super major, Expro’s team pulled off a feat that even industry veterans are calling a milestone. This kind of technical edge, especially in demanding offshore environments, puts Expro’s name front and center for...

If you have been watching Truist Financial (TFC) lately, you are not alone. There has not been a clear event driving headlines, but recent stock performance may be causing investors to wonder if something is shifting beneath the surface. Even without a single, obvious catalyst, a movement like this sparks curiosity. Does it hint at fresh opportunities or just day-to-day noise? Looking at the bigger picture, Truist Financial’s share price has posted a gain of roughly 14% over the year, while...

On September 2, 2025, Stewart Information Services Corporation announced a dividend increase, raising its annual cash dividend from US$2.00 to US$2.10 per share, with the updated quarterly payment beginning September 30, 2025, for shareholders of record as of September 16, 2025. This increase not only augments shareholder returns but also sends a signal of management's confidence in the company's financial outlook and earnings capacity. We'll explore what the recent dividend increase...

Realty Income (O) has popped up on watchlists again, and for investors keeping an eye on steady income stocks, that move alone raises questions. There hasn’t been a headline event or dramatic announcement to spur the shift, but subtle changes in sentiment can sometimes set the stage for something bigger. Whether you're a longtime holder or just considering adding Realty Income to your portfolio, it's a moment that invites a closer look at valuation rather than just following the crowd. Over...

AbCellera Biologics (NasdaqGS:ABCL) just took a key step forward by starting dosing in its Phase 1 clinical trial of ABCL575, a new antibody therapy for moderate-to-severe atopic dermatitis and potentially other autoimmune conditions. What sets ABCL575 apart is its engineering for a dosing schedule of just once every six months, a big shift from the more frequent regimens in today’s clinical landscape. This pipeline milestone shines a spotlight on AbCellera’s ambitions in finding...

Leggett & Platt's recent string of announcements has given investors something to consider. After finalizing the sale of its aerospace unit, which is expected to bring in $250 million in after-tax proceeds, the company also raised its full-year earnings guidance and projected a higher range for EPS than previously targeted. For anyone tracking this manufacturer, these moves signal a shift in business focus and an effort to sharpen profitability, both of which could impact how the stock is...

If you are eyeing New Fortress Energy (NFE) after its latest earnings drop, you are definitely not alone. The company just reported a much larger second-quarter net loss compared to last year, with results pressured by impairment charges and a substantial revenue decline after selling its Jamaican business. Management has responded by channeling the proceeds toward reducing debt and is openly evaluating further asset sales or capital-raising moves. This signals that liquidity and operational...

AAON reported its quarterly earnings, revealing both new growth opportunities and ongoing operational hurdles, alongside a downward revision in its financial guidance. Despite these challenges and insider stock sales by the CFO, the company highlights a solid BasX backlog and anticipated gains in production efficiency as reasons for confidence in future performance. We’ll explore how the recent earnings report and guidance update could shift AAON’s investment narrative, especially regarding...

Earlier this month, Dillard's released its second quarter 2025 Form 10-Q, reporting a slight increase in net sales fueled by strong juniors’ and children’s apparel growth, but also showing decreased sales in cosmetics and home furnishings. An interesting insight is management's focus on inventory control and risk management, addressing inflation and potential trade restrictions that could affect future operations. We'll explore how Dillard's commitment to inventory control and risk...

Have you been watching Marsh & McLennan Companies (MMC) lately? Investors might be scratching their heads over the stock’s movement, as the company has drifted quietly over the last month after a stretch of mixed results. With annual revenue and net income both growing in the single digits, but shares still down by double digits over the past year, it is no surprise that some are wondering if the market is missing something or seeing something others are not. The lack of an obvious event...

Mineralys Therapeutics recently announced new subgroup analyses from its Phase 3 Launch-HTN trial, revealing that lorundrostat significantly and consistently reduced blood pressure in high-risk, difficult-to-treat hypertensive patients while maintaining a favorable safety profile, with results presented at the 2025 American Heart Association Hypertension Scientific Sessions. This trial enrolled a diverse population reflective of real-world clinical settings, including substantial...

Immunovant announced six-month off-treatment data from a proof-of-concept study evaluating batoclimab in patients with active Graves' disease, which will be presented at the 2025 Annual Meeting of the American Thyroid Association on September 11. This long-term data highlights potential for batoclimab to manage thyroid hormone levels beyond the treatment period, indicating important clinical progress for the company. We'll explore how this newly released six-month follow-up data shapes...

In the past week, OneMain Holdings, through its subsidiary OneMain Finance Corporation, issued US$800 million in senior notes due 2033 to support general corporate purposes, potentially including debt repurchases or repayments. This move highlights OneMain’s proactive approach to managing its financial structure as it works to maintain flexibility and market positioning. To better understand the implications of this new debt issuance, we'll explore its impact on OneMain Holdings' overall...

If you are tracking Globalstar (GSAT) lately, you have probably noticed the wave of activity sparked by their recent announcement. The company is investing in new gateway infrastructure at OTE S.A.'s commercial teleport in Nemea, Greece, which is just one piece of a global push to upgrade its ground network for the advanced C-3 System. This expansion signals a major commitment to boosting the capabilities of Globalstar's satellite services, aiming to deliver next-generation connectivity to...